Kaye Foster
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Kaye Foster
Kaye Foster is recorded as Board Member at Agios Pharmaceuticals, Inc. (AGIO). Agios Pharmaceuticals, Inc. reported in an 8-K filed May 25, 2023 that Kaye Foster was appointed lead independent director, effective May 24, 2023.
“The Board, upon the recommendation of the Nominating and Corporate Governance Committee of the Board (the "Corporate Governance Committee"), appointed director Kaye Foster to serve as the Board's lead independent director and appointed director Cynthia Smith to serve as the chair of the Compensation & People Committee, succeeding Ms. Foster, each as of May 24, 2023.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-05-24–present
-
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Agios Pharmaceuticals, Inc.
Other people whose current roles at this company are on record from its filings.
- Brian Goff CEO, Board Member
- Jacqualyn Fouse CEO, Board Member
- David P. Schenkein Chairman
- Jacqualyn A. Fouse Chairman
- Cecilia Jones CFO
- T.J. Washburn Chief Accounting Officer
- Catherine Owen Adams Board Member
- Cynthia Smith Board Member
- David Scadden Board Member
- David Scadden, M.D. Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.